Results 31 to 40 of about 345,005 (304)

Amniotic fluid embolism pathophysiology suggests the new diagnostic armamentarium: β-tryptase and complement fractions C3-C4 are the indispensable working tools [PDF]

open access: yes, 2015
Amniotic fluid embolism (AFE) is an uncommon obstetric condition involving pregnant women during labor or in the initial stages after delivery. Its incidence is estimated to be around 5.5 cases per 100,000 deliveries.
Busardo', FRANCESCO PAOLO   +3 more
core   +2 more sources

Factor D Inhibition Blocks Complement Activation Induced by Mutant Factor B Associated With Atypical Hemolytic Uremic Syndrome and Membranoproliferative Glomerulonephritis

open access: yesFrontiers in Immunology, 2021
Complement factor B (FB) mutant variants are associated with excessive complement activation in kidney diseases such as atypical hemolytic uremic syndrome (aHUS), C3 glomerulopathy and membranoproliferative glomerulonephritis (MPGN).
Sigridur Sunna Aradottir   +8 more
doaj   +1 more source

Real-world clinical outcomes and treatment response in complement inhibitor experienced and naïve PNH patients prescribed pegcetacoplan in Europe and Canada

open access: yesHematology
Objectives This study investigated outcomes and response to pegcetacoplan in complement inhibitor naïve (CInaïve) and experienced (CIexp) PNH patients.Methods Data were drawn from the Adelphi PNH Disease Specific Programme™, a cross-sectional survey of ...
Jens Panse   +9 more
doaj   +1 more source

Blockade of the kallikrein-kinin system reduces endothelial complement activation in vascular inflammationResearch in context

open access: yesEBioMedicine, 2019
Background: The complement and kallikrein-kinin systems (KKS) are activated during vascular inflammation. The aim of this study was to investigate if blockade of the KKS can affect complement activation on the endothelium during inflammation.
Ingrid Lopatko Fagerström   +10 more
doaj   +1 more source

MASP-1 of the complement system enhances clot formation in a microvascular whole blood flow model. [PDF]

open access: yesPLoS ONE, 2018
The complement and coagulation systems closely interact with each other. These interactions are believed to contribute to the proinflammatory and prothrombotic environment involved in the development of thrombotic complications in many diseases ...
Lorenz Jenny   +5 more
doaj   +1 more source

The emerging role of complement inhibitors in transplantation [PDF]

open access: yesKidney International, 2015
The role of complement in the biology of kidney transplantation is becoming more and more significant, especially but not only because we now have access to drugs inhibiting complement. After describing the main characteristics of complement biology, both activation of the complement cascade and the many regulatory factors, we will review the precise ...
Véronique, Frémeaux-Bacchi   +1 more
openaire   +2 more sources

Deficiency of terminal complement pathway inhibitor promotes neuronal tau pathology and degeneration in mice

open access: yesJournal of Neuroinflammation, 2012
Background The neuronal microtubule-associated protein tau becomes hyperphosphorylated and forms aggregates in tauopathies but the processes leading to this pathological hallmark are not understood.
Britschgi Markus   +5 more
doaj   +1 more source

Hemopexin as an Inhibitor of Hemolysis-Induced Complement Activation

open access: yesFrontiers in Immunology, 2020
Hemopexin is the main plasmatic scavenger of cell-free heme, released in the context of intravascular hemolysis or major cell injury. Heme is indispensable for the oxygen transport by hemoglobin but when released outside of the erythrocytes it becomes a ...
Victoria Poillerat   +8 more
doaj   +1 more source

Sutimlimab for the Treatment of Cold Agglutinin Disease

open access: yesHemaSphere, 2023
Cold agglutinin disease (CAD) is a rare autoimmune hemolytic anemia and a bone marrow clonal lymphoproliferative disorder. Hemolysis in CAD is complement-dependent and mediated by the classical activation pathway.
Sigbjørn Berentsen
doaj   +1 more source

Complement Inhibitors And Glomerulonephritis [PDF]

open access: yesJournal of the American Society of Nephrology, 2003
I recently gave a talk at a European nephrologic gathering on future therapies for glomerulonephritis (GN). It relied heavily on data from established animal models of renal disease. At the end, the first comment came from a very stern and unhappy-looking clinical nephrologist at the back of ...
openaire   +1 more source

Home - About - Disclaimer - Privacy